Introduction: Cochlear implantation (CI) is an option for severe to profound hearing loss when hearing aids are ineffective. This study aimed to evaluate its relevance in individuals over 80 by assessing long-term CI use and audiological outcomes.
Methods: We conducted a retrospective, single-center study including 29 patients over 80years old who received their first CI between January 2012 and December 2021 with data recorded until December 2024. Annual rates of users and non-users, audiometric test results, and pre- and postoperative complications were recorded.
Results: The mean age at implantation was 82.8, and the mean duration of CI usage was 4.9years. The percentage of patients still using their implant was 100%, 93%, 83%%, 76% and 75% at 1, 2, 3, 4 and 5years respectively. This number dropped to 33% 8years after the surgery. The main reasons for discontinuation were loss of autonomy and lack of benefit. Audiometric results showed improvement in mean pure-tone audiometry thresholds and free-field speech audiometry. Minor complications occurred in 24% of cases, while severe complications occurred in 13%.
Conclusion: CI is a viable option for patients over 80years old with severe to profound hearing loss. However, given the progressive decline of usage after implantation in this age group, a detailed cost-benefit analysis could provide valuable insight into its indication for this population.
Objectives: This study aimed to measure and compare nasal mucus cystatin SN levels in patients with controlled and uncontrolled chronic rhinosinusitis, and to evaluate its diagnostic performance in distinguishing between these disease states.
Material and methods: A total of 98 CRS patients were prospectively enrolled and evaluated for disease control based on the EPOS criteria. Specimens of nasal mucus and tissue from patients with CRS and 15 healthy controls undergoing surgery for the deviated septum were obtained to measure cystatin SN levels. Disease severity was evaluated using the 22-item Sinonasal Outcome Test (SNOT-22), Questionnaire of Olfactory Disorders Negative Statements (QOD-NS) score, Lund-Kennedy score, Lund-Mackay score, olfactory cleft endoscopy scale (OCES), and olfactory cleft computed tomography (CT) score. Multivariable logistic regression analysis was used to determine the risk factors associated with uncontrolled CRS.
Results: Among the patients with CRS, 42.86% were uncontrolled. Cystatin SN expression in the nasal epithelium was significantly increased among patients with uncontrolled CRS compared to those with controlled CRS and healthy controls (both P<0.001). Furthermore, the uncontrolled CRS exhibited significantly higher blood eosinophil counts (BEC) (P=0.001), SNOT-22 score (P=0.001), QOD-NS score (P=0.004), Lund-Mackay score (P=0.022), OCES (P=0.004), and olfactory cleft CT score (P=0.012) than controlled CRS. Additionally, mucus cystatin SN levels showed a positive correlation with BEC (R=0.126, P=0.012) in patients with CRS. Multivariable logistic regression analysis showed that nasal mucus cystatin SN was identified as an independent predictor of uncontrolled CRS (OR=1.011, P=0.028). Mucus cystatin SN levels with a cutoff point greater than 106.050pg/mL had a superior predictive value for uncontrolled CRS compared to BEC (area under the curve, 0.886 vs. 0.782, P<0.001).
Conclusion: Mucus cystatin SN levels were highly associated with disease severity in patients with uncontrolled CRS.

